Comparison of Dapagliflozin, Lobeglitazone, and Its Combination in Efficacy and Safety
Condition: Diabetes Type 2 Interventions: Drug: Dapagliflozin 10mg Tab; Drug: Lobeglitazone 0.5 mg; Drug: Dapagliflozin + Lobeglitazone Sponsor: Seoul National University Bundang Hospital Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials